During the past decade, FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy" conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" #1 collaborator was "BeiGene" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" are "Advanced or Metastatic Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" in a lesser frequency.

Most popular intervention types in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" are "Drug" (6 trials), "Biological" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy", 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".